Baltimore Buprenorphine Initiative
|
Instructions for Physicians who would like to obtain a waiver to prescribe Buprenorphine |
Step 1: Enroll in Online Training course via: Online Registration or Paper Registration |
Step 2: After receiving an email with your UserID and Password, complete the online training course within 3 months |
Step 3: Complete and Submit the Data 2000 Waiver Application (Online Application; Paper Application ) |
Questions? Contact:
Vanessa Kuhn
Buprenorphine Program Coordinator
Baltimore Substance Abuse Systems, Inc.
One North Charles Street., Ste 1600
Baltimore, MD 21201-3718
(410) 637-1900 ext.286
Fax: (410) 649-1911
vkuhn@bsasinc.org
|
Baltimore City Health Department is proud to
announce the Baltimore Buprenorphine Initiative. This collaborative effort with
Baltimore HealthCare Access and Baltimore Substance
Abuse Systems will dramatically increase substance abuse
treatment options in Baltimore.
For
decades, Baltimore has had one of the highest rates of
heroin addiction in the nation and the demand for heroin
treatment exceeds supply. We are bringing
together substance abuse treatment centers, community
health centers and primary care physicians to
collectively join the fight against heroin addiction in
Baltimore City.
The Baltimore Buprenorphine Initiative Interim Progress Report
-Appendices to Interim Report
The project has three major
components:
1. Recruiting physicians across the city to obtain a
waiver to prescribe buprenorphine. Free training will be
provided to eligible physicians so they can obtain a
waiver to prescribe buprenorphine.
2.
Drug Treatment. Six substance abuse treatment
centers in Baltimore City funded by Baltimore Substance
Abuse Systems will provide drug treatment including dose
induction, stabilization, and continuance on
buprenorphine along with intensive outpatient counseling
to opioid dependent patients.
3. Extended buprenorphine therapy. BHCA staff are
working closely with substance abuse treatment centers
to enroll clients into available public benefits
programs and transferring stabilized patients with
pharmacy benefits to community-based physicians in
community health centers and other settings.
|
